top
Search terms
Results 1 - 10 of 13 - ordered by :
Pages: 1 2
Ehjournal

Aims The prognostic implication of adiposity on clinical outcomes in atrial fibrillation (AF) patients treated with oral anticoagulation is unclear. Methods and results A total of 17 913 patients in ...

European Heart Journal, Sandhu, Roopinder K., Ezekowitz, Justin, Andersson, Ulrika, Alexander, John H., Granger, Christopher B., Halvorsen, Sigrun, Hanna, Michael, Hijazi, Ziad, Jansky, Petr, Lopes, ...

Date : 07/10/2016 Item size : 305139 bytes
Ehjournal

Introduction Oral anticoagulation is recommended for the prevention of thromboembolic events in patients with atrial fibrillation (AF) at risk for stroke.13 Oral anticoagulants have been shown to be ...

European Heart Journal, Alexander, John H., Lopes, Renato D., Thomas, Laine, Alings, Marco, Atar, Dan, Aylward, Philip, Goto, Shinya, Hanna, Michael, Huber, Kurt, Husted, Steen, Lewis, Basil S., ...

Date : 21/01/2014 Item size : 298281 bytes
Ehjournal

Abstract Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of stroke, major bleed, ...

European Heart Journal, Held, Claes, Hylek, Elaine M., Alexander, John H., Hanna, Michael, Lopes, Renato D., Wojdyla, Daniel M., Thomas, Laine, Al-Khalidi, Hussein, Alings, Marco, Xavier, Dennis, ...

Date : 21/05/2015
Ehjournal

Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial Methods and results ...

European Heart Journal, Vinereanu, Dragos, Stevens, Susanna R., Alexander, John H., Al-Khatib, Sana M., Avezum, Alvaro, Bahit, Marıa Cecilia, Granger, Christopher B., Lopes, Renato D., Halvorsen, ...

Date : 07/12/2015 Item size : 304609 bytes
Ehjournal

See page 2429 for the editorial comment on this article (doi:10.1093/eurheartj/eht205) Introduction One of the most serious complications of atrial fibrillation (AF) is stroke.1 Not only is stroke ...

European Heart Journal, Al-Khatib, Sana M., Thomas, Laine, Wallentin, Lars, Lopes, Renato D., Gersh, Bernard, Garcia, David, Ezekowitz, Justin, Alings, Marco, Yang, Hongqui, Alexander, John H., ...

Date : 14/08/2013
Ehjournal

The cardiac biomarkers N-terminal fragment B-type natriuretic peptide (NT-proBNP) and cardiac troponin high-sensitivity (cTn-hs) are independently associated with risk of stroke in AF. Methods and ...

European Heart Journal, Hijazi, Ziad, Lindbäck, Johan, Alexander, John H., Hanna, Michael, Held, Claes, Hylek, Elaine M., Lopes, Renato D., Oldgren, Jonas, Siegbahn, Agneta, Stewart, Ralph A.H., ...

Date : 21/05/2016
Ehjournal

Introduction Oral anticoagulation is recommended for the prevention of thromboembolic events in patients with atrial fibrillation (AF) at risk for stroke.13 Oral anticoagulants have been shown to be ...

European Heart Journal, Alexander, John H., Lopes, Renato D., Thomas, Laine, Alings, Marco, Atar, Dan, Aylward, Philip, Goto, Shinya, Hanna, Michael, Huber, Kurt, Husted, Steen, Lewis, Basil S., ...

Date : 21/01/2014
Ehjournal

See page 2429 for the editorial comment on this article (doi:10.1093/eurheartj/eht205) Introduction One of the most serious complications of atrial fibrillation (AF) is stroke.1 Not only is stroke ...

European Heart Journal, Al-Khatib, Sana M., Thomas, Laine, Wallentin, Lars, Lopes, Renato D., Gersh, Bernard, Garcia, David, Ezekowitz, Justin, Alings, Marco, Yang, Hongqui, Alexander, John H., ...

Date : 14/08/2013 Item size : 259318 bytes
Ehjournal

According to baseline CockcroftGault, there were 7518 patients (42%) with an estimated GFR (eGFR) of >80 mL/min, 7587 (42%) between >50 and 80 mL/min, and 3017 (15%) with an eGFR of 50 mL/min. See ...

European Heart Journal, Hohnloser, Stefan H., Hijazi, Ziad, Thomas, Laine, Alexander, John H., Amerena, John, Hanna, Michael, Keltai, Matyas, Lanas, Fernando, Lopes, Renato D., Lopez-Sendon, Jose, ...

Date : 01/11/2012 Item size : 268417 bytes
Ehjournal

Abstract Aim In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial, apixaban compared with warfarin reduced the risk of stroke, major bleed, ...

European Heart Journal, Held, Claes, Hylek, Elaine M., Alexander, John H., Hanna, Michael, Lopes, Renato D., Wojdyla, Daniel M., Thomas, Laine, Al-Khalidi, Hussein, Alings, Marco, Xavier, Dennis, ...

Date : 21/05/2015 Item size : 332513 bytes